MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0001499
Admiron Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.41 Cr
▼ 43% YoY
Net loss · FY 2024
₹3.2 Cr
Net margin -10.9%
EBITDA · FY 2024
₹2.19 Cr
EBITDA margin 7.5%
Authorised capital
₹45 Cr
Registered with MCA
Paid-up capital
₹42.39 Cr
Issued & subscribed
Open charges
₹16.44 Cr
Satisfied ₹98.25 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
124
Provident fund records
About Admiron Life Sciences Private Limited
Data last updated:
Admiron Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC071534. Its GSTIN is 36AAJCA0140R2ZH (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹42.39 Cr. It is led by directors including Sainadh Reddy Thatiparthi and Govinda Reddy Balineni.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.41 Cr, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹3.2 Cr (net margin -10.9%) and EBITDA of ₹2.19 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 24% over five years.
The company has about 124 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.44 Cr and satisfied charges of ₹98.25 Cr on record. Court records list 14 cases involving the company, including 1 filed by the company and 13 filed against it; 3 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Rasayan Drugs Private Limited with revenue of ₹29.92 Cr.
Admiron Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0001499). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website admironls.com.
Company details
CIN U24232TG2010PTC071534
Registration Number 071534
Incorporation Date 06 December 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0001499
CIN history
Admiron Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2010PTC071534. The current CIN is U24232TG2010PTC071534, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC071534 | Current |
| U24232AP2010PTC071534 | Previous |
Key People
Sainadh Reddy Thatiparthi Director Govinda Reddy Balineni Director Kanigiri Gade Director Recognitions & Rankings of Admiron Life Sciences
Contact details
Admiron Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is admironls.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 754 1st Floor Road No.38, Sri Swamy Ayyappa Society, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Admiron Life Sciences Private Limited, buy the company report.
Comprehensive company report
Admiron Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Admiron Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Admiron Life Sciences Private Limited, buy the company report.
Financials of Admiron Life Sciences Private Limited
FY 2024 filings availableAdmiron Life Sciences Private Limited reported revenue of ₹29.41 Cr (down 43% YoY) for FY 2024.
Revenue · FY 2024
₹29.41 Cr ▼ 43%
Net loss · FY 2024
₹3.2 Cr margin -10.9%
EBITDA · FY 2024
₹2.19 Cr margin 7.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▲ 9%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 61%
3 years · compounded
▲ 22%
5 years · compounded
▲ 8%
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | -10.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Admiron Life Sciences Private Limited, buy the company report.
Board of directors of Admiron Life Sciences Private Limited
Admiron Life Sciences has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sainadh Reddy Thatiparthi Also directs: Aarishi Medkare Private Limited, Pranaya Life Sciences Private Limited, Pranaya Parenterals Private Limited and 2 more | Director | 08 Jul 2023 | 3 Years 4 Months | Current |
| Govinda Reddy Balineni | Director | 23 Dec 2019 | 6 Years 10 Months | Current |
| Kanigiri Gade Also directs: Aarishi Medkare Private Limited, Pranaya Life Sciences Private Limited, Pranaya Parenterals Private Limited and 1 more | Director | 08 Jul 2023 | 3 Years 4 Months | Current |
Peer comparison
Admiron Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rasayan Drugs Private Limited | ₹29.92 Cr (FY 2024) | 132.0% | Solapur, Maharashtra, India | |||
| Lofty Laboratories Private Limited | ₹29.82 Cr (FY 2025) | 119.0% | Hyderabad, Telangana, India | |||
| Magnum Chemi-Gran Private Limited | ₹29.74 Cr (FY 2025) | 38.0% | Hyderabad, Telangana, India | |||
| Admiron Life Sciences Private Limitedthis company | ₹29.41 Cr (FY 2024) | -₹3.2 Cr | -10.9% | -43.0% | 124 | Hyderabad, Telangana, India |
| G.M. Chemie Private Limited | ₹29.36 Cr (FY 2025) | 43.0% | Navi Mumbai, Maharashtra, India | |||
| Trimax Bio Sciences Private Limited | ₹29.26 Cr (FY 2025) | -49.0% | Hyderabad, Telangana, India | |||
| Stellence Pharmscience Private Limited | ₹29.16 Cr (FY 2022) | -16.0% | Bangalore, Karnataka, India | |||
| Asg Biochem Private Limited | ₹28.92 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India |
To see the full peer comparison of Admiron Life Sciences Private Limited, buy the company report.
Auditor
Admiron Life Sciences Private Limited is audited by SARATH & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARATH & ASSOCIATES | FY 2022 | 005120S |
Shareholding
The shareholding of Admiron Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Admiron Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.44 Cr
Satisfied charges
₹98.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 2021 | 100448804 | Hdfc Bank Limited | ₹16.25 Cr | Open | |
| 31 Dec 2020 | 100411414 | Others | ₹18.7 Lakh | Open | |
| 24 Dec 2013 | 10477515 | State Bank of Hyderabad | ₹59.25 Cr | Satisfied | |
| 07 Jul 2012 | 10370204 | State Bank of Hyderabad | ₹39 Cr | Satisfied |
To see the full charge records of Admiron Life Sciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Admiron Life Sciences Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019.
Total deals
7
Secondary share transfers
4
Funding rounds
3
Disclosed funding
₹42.38 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Aarishi Medkare Private Limited , an individual Seller: 4 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Pranaya Pharmacy INC Seller: Pranaya Realtors INC |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2014 | Funding round | ₹13.24 Cr | Investors: Shrineeta Pharmacy INC, 3 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Admiron Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Admiron Life Sciences Private Limited has 14 court cases on record: 1 filed by Admiron Life Sciences, 13 filed against it. 3 cases are pending and 11 are disposed.
Total cases
14
Filed by the company
1
Filed against the company
13
Pending
3
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
| High courts | 7 | 6 | 3 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd and 1 other | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Ms Black Rose Trading Pvt. Ltd. | Disposed |
| High Court of Andhra Pradesh | Revision petition | Filed against the company | Pending |
| High Court for State of Telangana | Writ petition | Filed against the company | Pending |
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Pending |
To see the full case history of Admiron Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Admiron Life Sciences Private Limited was last rated by Care on 03 Jul 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 03 Jul 2018 |
To see the full credit ratings and regulatory alerts of Admiron Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admiron Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Admiron Life Sciences Private Limited has a workforce of 124 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
124
Active EPFO establishments
1
Employee growth
-6.06%
GST
Admiron Life Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA0140R2ZH | Telangana | Active | 11 Jan 2019 |
| 37AAJCA0140R1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Admiron Life Sciences Private Limited, buy the company report.
Recent activity
Admiron Life Sciences Private Limited has 13 board changes on record since 2019: 3 appointments and 10 cessations. The latest: Kanigiri Gade was appointed as Director on 08 Jul 2023.
AGM
Admiron Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Admiron Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Kanigiri Gade was appointed as Director.
Appointed
Sainadh Reddy Thatiparthi was appointed as Director.
Ceased
Anji Reddy Tatiparthi ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.25 Cr with Charge ID 100448804 was registered on 20 May 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 16.25 Cr registered on 20 May 2021 with Charge ID 100448804 was modified on 20 May 2021.
Charges
A charge with Others amounted to Rs. 0.19 Cr with Charge ID 100411414 was registered on 31 Dec 2020.
Ceased
Sanagala Sridhar Reddy ceased to be Additional Director.
Ceased
Ravi Pallapolu ceased to be Director.
Ceased
Sambi Reddy Bhimi Reddy ceased to be Director.
Ceased
Susheela Bhimireddy ceased to be Director.
12 earlier events are in the company report.
Frequently asked questions
Admiron Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 December 2010 (16+ years old) and is registered under CIN U24232TG2010PTC071534.
Admiron Life Sciences has 3 current directors:
- Sainadh Reddy Thatiparthi - Director
- Govinda Reddy Balineni - Director
- Kanigiri Gade - Director
The latest financial statements of Admiron Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Admiron Life Sciences is 36AAJCA0140R2ZH, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAJCA0140R1ZG (Andhra Pradesh).
The CIN (Corporate Identification Number) of Admiron Life Sciences is U24232TG2010PTC071534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admiron Life Sciences has 14 court cases on record: 1 filed by the company and 13 filed against it. 3 are pending. Most are in the district courts.
Admiron Life Sciences was incorporated on 06 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Admiron Life Sciences has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.38 Cr; the latest was in March 2019.
The peers of Admiron Life Sciences by revenue are Rasayan Drugs Private Limited, Lofty Laboratories Private Limited, Magnum Chemi-Gran Private Limited, G.M. Chemie Private Limited, Trimax Bio Sciences Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kanigiri Gade was appointed as Director on 08 Jul 2023. Sainadh Reddy Thatiparthi was appointed as Director on 08 Jul 2023. Anji Reddy Tatiparthi ceased to be Director on 25 Mar 2022. Admiron Life Sciences has 13 board changes on record in total.
Yes, Admiron Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0001499).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages